Crawford Investment Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,229
| Closed | -$818K | – | 283 |
|
|
2021
Q3 | $818K | Sell |
7,229
-7
| -0.1% | -$792 | 0.02% | 203 |
|
|
2021
Q2 | $749K | Buy |
7,236
+18
| +0.2% | +$1.86K | 0.02% | 207 |
|
|
2021
Q1 | $604K | Buy |
7,218
+45
| +0.6% | +$3.77K | 0.01% | 205 |
|
|
2020
Q4 | $654K | Buy |
7,173
+60
| +0.8% | +$5.47K | 0.02% | 196 |
|
|
2020
Q3 | $568K | Buy |
7,113
+171
| +2% | +$13.7K | 0.02% | 197 |
|
|
2020
Q2 | $480K | Hold |
6,942
| – | – | 0.01% | 206 |
|
|
2020
Q1 | $436K | Sell |
6,942
-6
| -0.1% | -$377 | 0.01% | 208 |
|
|
2019
Q4 | $540K | Buy |
6,948
+6
| +0.1% | +$466 | 0.01% | 216 |
|
|
2019
Q3 | $509K | Buy |
+6,942
| New | +$509K | 0.01% | 215 |
|
|
2017
Q3 | – | Sell |
-6,300
| Closed | -$248K | – | 244 |
|
|
2017
Q2 | $248K | Sell |
6,300
-300
| -5% | -$11.8K | 0.01% | 220 |
|
|
2017
Q1 | $207K | Buy |
+6,600
| New | +$207K | 0.01% | 237 |
|
|
2016
Q4 | – | Sell |
-6,900
| Closed | -$277K | – | 253 |
|
|
2016
Q3 | $277K | Hold |
6,900
| – | – | 0.01% | 219 |
|
|
2016
Q2 | $229K | Hold |
6,900
| – | – | 0.01% | 235 |
|
|
2016
Q1 | $203K | Buy |
+6,900
| New | +$203K | 0.01% | 240 |
|
|
2015
Q1 | – | Sell |
-13,164
| Closed | -$279K | – | 240 |
|
|
2014
Q4 | $279K | Hold |
13,164
| – | – | 0.01% | 219 |
|
|
2014
Q3 | $224K | Buy |
+13,164
| New | +$224K | 0.01% | 228 |
|